At Lakeside, we aim to transform rheumatology by enhancing patient care through innovative research and treatments. We believe in collaboration, bringing together experts to improve our understanding and management of rheumatic diseases. Join us in redefining the future of rheumatology.
This Phase 4 study is enrolling adults with early polymyalgia rheumatica (PMR) to evaluate sarilumab, a medication that targets inflammation. Participants will receive either sarilumab...
Duration
This study tested whether adding an investigational drug called Natrunix to the standard RA medication methotrexate (plus folate) is safe and more effective than methotrexate...
Duration
This study tested a new molecular tool (called a “response classifier”) that analyzes a patient’s biology to predict which type of medication — a JAK...
Duration
This open-label, long-term extension study allowed patients who had already completed a previous Novartis-sponsored secukinumab study to continue receiving secukinumab treatment if their doctor believed...
Duration
Clinical trials offer unique opportunities to access new treatments while contributing to medical advancement.
Read what participants are saying about our treatments.
